Literature DB >> 21769988

Information about chemotherapy-associated cognitive problems contributes to cognitive problems in cancer patients.

Sanne B Schagen1, Enny Das, Ivar Vermeulen.   

Abstract

OBJECTIVE: Although increasing attention is directed at identifying biological mechanisms underlying cognitive changes observed in cancer patients without central nervous system disease following chemotherapy, psychological factors that can contribute to these cognitive changes are much less studied.
METHODS: In an online experiment, the influence of informing patients about the association between cognitive problems and chemotherapy on self-reported cognitive functioning and neuropsychological test performance was investigated.
RESULTS: Cancer patients treated with chemotherapy (n = 150) reported higher levels of cognitive complaints after receiving such information (M = 21.20) than without such information (M = 18.98; p = 0.032). No difference was found for patients without (a history of) chemotherapy (n = 86; M = 18.85 vs. 20.08; NS). A similar interaction pattern was observed on a word-learning test. Patients treated with chemotherapy recalled fewer words after being informed about the association between cognitive problems and chemotherapy (M = 24.44) than without such information (M = 27.63; p = 0.010). No difference was found for patients not treated with chemotherapy (M = 26.35 vs. 25.38; NS).
CONCLUSION: Patient information may induce a stereotype threat, which affects self-reported cognitive function and neuropsychological test performance in cancer patients for whom this information is relevant.
Copyright © 2011 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21769988     DOI: 10.1002/pon.2011

Source DB:  PubMed          Journal:  Psychooncology        ISSN: 1057-9249            Impact factor:   3.894


  20 in total

Review 1.  Psychosocial care in cancer.

Authors:  Samantha B Artherholt; Jesse R Fann
Journal:  Curr Psychiatry Rep       Date:  2012-02       Impact factor: 5.285

Review 2.  Taxane-induced neurotoxicity: Pathophysiology and therapeutic perspectives.

Authors:  Robson da Costa; Giselle F Passos; Nara L M Quintão; Elizabeth S Fernandes; João Raphael L C B Maia; Maria Martha Campos; João B Calixto
Journal:  Br J Pharmacol       Date:  2020-06-03       Impact factor: 8.739

Review 3.  Cancer-related cognitive impairment: an update on state of the art, detection, and management strategies in cancer survivors.

Authors:  M Lange; F Joly; J Vardy; T Ahles; M Dubois; L Tron; G Winocur; M B De Ruiter; H Castel
Journal:  Ann Oncol       Date:  2019-12-01       Impact factor: 32.976

4.  Yoga and self-reported cognitive problems in breast cancer survivors: a randomized controlled trial.

Authors:  Heather M Derry; Lisa M Jaremka; Jeanette M Bennett; Juan Peng; Rebecca Andridge; Charles Shapiro; William B Malarkey; Charles F Emery; Rachel Layman; Ewa Mrozek; Ronald Glaser; Janice K Kiecolt-Glaser
Journal:  Psychooncology       Date:  2014-10-21       Impact factor: 3.894

Review 5.  Broadening the cancer and cognition landscape: the role of self-regulatory challenges.

Authors:  Jamie Arndt; Enny Das; Sanne B Schagen; Stephanie A Reid-Arndt; Linda D Cameron; Tim A Ahles
Journal:  Psychooncology       Date:  2013-07-10       Impact factor: 3.894

Review 6.  Cognitive Impairment Associated with Cancer: A Brief Review.

Authors:  J Cara Pendergrass; Steven D Targum; John E Harrison
Journal:  Innov Clin Neurosci       Date:  2018-02-01

7.  Scale-free brain dynamics under physical and psychological distress: pre-treatment effects in women diagnosed with breast cancer.

Authors:  Nathan W Churchill; Bernadine Cimprich; Mary K Askren; Patricia A Reuter-Lorenz; Mi Sook Jung; Scott Peltier; Marc G Berman
Journal:  Hum Brain Mapp       Date:  2014-11-11       Impact factor: 5.038

8.  Systematic review of self-reported cognitive function in cancer patients following chemotherapy treatment.

Authors:  Victoria J Bray; Haryana M Dhillon; Janette L Vardy
Journal:  J Cancer Surviv       Date:  2018-05-04       Impact factor: 4.442

9.  Survivorship: cognitive function, version 1.2014.

Authors:  Crystal S Denlinger; Jennifer A Ligibel; Madhuri Are; K Scott Baker; Wendy Demark-Wahnefried; Debra L Friedman; Mindy Goldman; Lee Jones; Allison King; Grace H Ku; Elizabeth Kvale; Terry S Langbaum; Kristin Leonardi-Warren; Mary S McCabe; Michelle Melisko; Jose G Montoya; Kathi Mooney; Mary Ann Morgan; Javid J Moslehi; Tracey O'Connor; Linda Overholser; Electra D Paskett; Muhammad Raza; Karen L Syrjala; Susan G Urba; Mark T Wakabayashi; Phyllis Zee; Nicole R McMillian; Deborah A Freedman-Cass
Journal:  J Natl Compr Canc Netw       Date:  2014-07       Impact factor: 11.908

10.  Acknowledging the relevance of cognitive changes in cancer patients: perspectives of oncology practitioners in Asia.

Authors:  Yin Ting Cheung; Maung Shwe; Earl Hsien Jie Tan; Wai Keung Chui; Raymond Ng; Alexandre Chan
Journal:  J Cancer Surviv       Date:  2013-02-08       Impact factor: 4.442

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.